Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16546624 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
Condition: Iron Deficiency Anemia
Interventions: Drug: Ferumoxytol;   Drug: Ferric carboxymaltose
2 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:

Indicates status has not been verified in more than two years